The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease

Progress in Brain Research

Volumn 172, Issue , 2008, Pages 233-264

  Michelsen, Kimmo A ^a   Prickaerts, Jos ^a   Steinbusch, Harry W M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; dorsal raphe nucleus; major depression; neuroplasticity; serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; ENKEPHALIN; GLUTAMIC ACID; HISTAMINE; IPRONIAZID; NEUROPEPTIDE Y; NEUROTRANSMITTER; NITRIC OXIDE; PAROXETINE; RESERPINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; TRYPTOPHAN HYDROXYLASE 2;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANXIETY; ANXIETY DISORDER; BRAIN CORTEX; BRAIN STEM; CEREBELLUM; CORPUS STRIATUM; DORSAL RAPHE NUCLEUS; ELECTROCONVULSIVE THERAPY; EPENDYMA; GLOBUS PALLIDUS; HABENULA; HIPPOCAMPUS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; MAJOR DEPRESSION; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PUTAMEN; REM SLEEP; REVIEW; RISK FACTOR; SEPTUM PELLUCIDUM; SEROTONINERGIC NERVE CELL; SPINAL CORD; SUBSTANTIA NIGRA; SYNAPTOGENESIS; THALAMUS;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL SHAPE; DEPRESSIVE DISORDER, MAJOR; HUMANS; NEURAL PATHWAYS; NEURONAL PLASTICITY; NEURONS; NEUROTRANSMITTER AGENTS; RAPHE NUCLEI; RECEPTORS, SEROTONIN; RISK FACTORS; SEROTONIN;

EID: 50649122969     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00912-6     Document Type: Review

References (280)

1. Abrams J.K., Johnson P.L., Hollis J.H., and Lowry C.A. Anatomic and functional topography of the dorsal raphe nucleus. Ann. N.Y. Acad. Sci. 1018 (2004) 46-57
2. Aghajanian G.K., and Gallager D.W. Raphe origin of serotonergic nerves terminating in the cerebral ventricles. Brain Res. 88 (1975) 221-231
3. Aletrino M.A., Vogels O.J., Van Domburg P.H., and ten Donkelaar H.J. Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiol. Aging 13 (1992) 461-468
4. Alheid G.F., and Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27 (1988) 1-39
5. Allers K.A., and Sharp T. Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience 122 (2003) 193-204
6. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., de Girolamo G., Graaf R., Demyttenaere K., Gasquet I., Haro J.M., Katz S.J., Kessler R.C., Kovess V., Lepine J.P., Ormel J., Polidori G., Russo L.J., Vilagut G., Almansa J., Arbabzadeh-Bouchez S., Autonell J., Bernal M., Buist-Bouwman M.A., Codony M., Domingo-Salvany A., Ferrer M., Joo S.S., Martinez-Alonso M., Matschinger H., Mazzi F., Morgan Z., Morosini P., Palacin C., Romera B., Taub N., and Vollebergh W.A. Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta. Psychiatr. Scand. Suppl. (2004) 21-27
7. Altman J., and Das G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 124 (1965) 319-335
8. Anden N.E., Dahlstrom A., Fuxe K., and Larsson K. Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci. 4 (1965) 1275-1279
9. Araneda S., Bobillier P., Buda M., and Pujol J.F. Retrograde axonal transport following injection of [3H]serotonin in the olfactory bulb. I. Biochemical study. Brain Res. 196 (1980) 405-415
10. Araneda S., Gamrani H., Font C., Calas A., Pujol J.F., and Bobillier P. Retrograde axonal transport following injection of [3H]-serotonin into the olfactory bulb. II. Radioautographic study. Brain Res. 196 (1980) 417-427
11. Arvidsson U., Cullheim S., Ulfhake B., Luppi P.H., Kitahama K., Jouvet M., and Hokfelt T. Quantitative and qualitative aspects on the distribution of 5-HT and its coexistence with substance P and TRH in cat ventral medullary neurons. J. Chem. Neuroanat. 7 (1994) 3-12
12. Auvinen S., and Panula P. Development of histamine-immunoreactive neurons in the rat brain. J. Comp. Neurol. 276 (1988) 289-303
13. Azmitia E.C. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 21 (1999) 33S-45S
14. Azmitia E.C., Rubinstein V.J., Strafaci J.A., Rios J.C., and Whitaker-Azmitia P.M. 5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Brain Res. 677 (1995) 181-192
15. Azmitia E.C., and Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179 (1978) 641-667
16. Bach-Mizrachi H., Underwood M.D., Kassir S.A., Bakalian M.J., Sibille E., Tamir H., Mann J.J., and Arango V. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 31 (2006) 814-824
17. Baker K.G., Halliday G.M., Hornung J.P., Geffen L.B., Cotton R.G., and Tork I. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience 42 (1991) 757-775
18. Baker K.G., Halliday G.M., and Tork I. Cytoarchitecture of the human dorsal raphe nucleus. J. Comp. Neurol. 301 (1990) 147-161
19. Banasr M., Hery M., Printemps R., and Daszuta A. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 29 (2004) 450-460
20. Bath K.G., and Lee F.S. Variant BDNF (Val66Met) impact on brain structure and function. Cogn. Affect. Behav. Neurosci. 6 (2006) 79-85
21. Baumann B., Bielau H., Krell D., Agelink M.W., Diekmann S., Wurthmann C., Trubner K., Bernstein H.G., Danos P., and Bogerts B. Circumscribed numerical deficit of dorsal raphe neurons in mood disorders. Psychol. Med. 32 (2002) 93-103
22. Belin M.F., Aguera M., Tappaz M., McRae-Degueurce A., Bobillier P., and Pujol J.F. GABA-accumulating neurons in the nucleus raphe dorsalis and periaqueductal gray in the rat: a biochemical and radioautographic study. Brain Res. 170 (1979) 279-297
23. Bhatnagar S., Viau V., Chu A., Soriano L., Meijer O.C., and Dallman M.F. A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J. Neurosci. 20 (2000) 5564-5573
24. Blakely R.D. Overview: a rare opportunity or just one less reason to be depressed. Neuron 48 (2005) 701-702
25. Bobillier P., Seguin S., Petitjean F., Salvert D., Touret M., and Jouvet M. The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography. Brain Res. 113 (1976) 449-486
26. Boldrini M., Underwood M.D., Mann J.J., and Arango V. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res. 1041 (2005) 19-28
27. Braak H. Über die Kerngebiete de menschlichen Hirnstammes. II Die Raphekerne. Z. Zellforsch. Mikrosk. Anat. 107 (1970) 123-141
28. Brezun J.M., and Daszuta A. Serotonergic reinnervation reverses lesion-induced decreases in PSA-NCAM labeling and proliferation of hippocampal cells in adult rats. Hippocampus 10 (2000) 37-46
29. Brown P., and Molliver M.E. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J. Neurosci. 20 (2000) 1952-1963
30. Budas G., Coughlan C.M., Seckl J.R., and Breen K.C. The effect of corticosteroids on amyloid beta precursor protein/amyloid precursor-like protein expression and processing in vivo. Neurosci. Lett. 276 (1999) 61-64
31. Bunney B.S., and Aghajanian G.K. The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique. Brain Res. 117 (1976) 423-435
32. Burbach G.J., Hellweg R., Haas C.A., Del Turco D., Deicke U., Abramowski D., Jucker M., Staufenbiel M., and Deller T. Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J. Neurosci. 24 (2004) 2421-2430
33. Burnet P.W., Mefford I.N., Smith C.C., Gold P.W., and Sternberg E.M. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat. J. Neurochem. 59 (1992) 1062-1070
34. Carroll J.C., Boyce-Rustay J.M., Millstein R., Yang R., Wiedholz L.M., Murphy D.L., and Holmes A. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav. Genet. 37 (2007) 214-222
35. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
36. Chalmers D.T., Lopez J.F., Vazquez D.M., Akil H., and Watson S.J. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology 10 (1994) 215-222
37. Chan-Palay V. Serotonin axons in the supra- and subependymal plexuses and in the leptomeninges; their roles in local alterations of cerebrospinal fluid and vasomotor activity. Brain Res. 102 (1976) 103-130
38. Chan-Palay V., Jonsson G., and Palay S.L. Serotonin and substance P coexist in neurons of the rat's central nervous system. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 1582-1586
39. Cheetham S.C., Crompton M.R., Katona C.L., and Horton R.W. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 443 (1988) 272-280
40. Cheetham S.C., Crompton M.R., Katona C.L., and Horton R.W. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl.) 102 (1990) 544-548
41. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50 (2001) 260-265
42. Chen C.P.L., Eastwood S.L., Hope T., McDonald B., Francis P.T., and Esiri M.M. Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol. Appl. Neurobiol. 26 (2000) 347-355
43. Chen L., Hamaguchi K., Ogawa M., Hamada S., and Okada N. PCPA reduces both monoaminergic afferents and nonmonoaminergic synapses in the cerebral cortex. Neurosci. Res. 19 (1994) 111-115
44. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., and Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314 (2006) 140-143
45. Commons K.G., Connolley K.R., and Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28 (2003) 206-215
46. Connor B., Young D., Yan Q., Faull R.L., Synek B., and Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 49 (1997) 71-81
47. Conrad L.C., Leonard C.M., and Pfaff D.W. Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study. J. Comp. Neurol. 156 (1974) 179-205
48. Cortes R., Ceccatelli S., Schalling M., and Hokfelt T. Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 6 (1990) 369-391
49. Croll S.D., Ip N.Y., Lindsay R.M., and Wiegand S.J. Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res. 812 (1998) 200-208
50. Cross A.J., Crow T.J., Ferrier I.N., Johnson J.A., Bloom S.R., and Corsellis J.A. Serotonin receptor changes in dementia of the Alzheimer type. J. Neurochem. 43 (1984) 1574-1581
51. Curcio C.A., and Kemper T. Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J. Neuropathol. Exp. Neurol. 43 (1984) 359-368
52. D'Sa C., and Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord. 4 (2002) 183-194
53. Dahlstrom A., and Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62 Suppl. (1964) 55
54. Davis K.L., Davis B.M., Greenwald B.S., Mohs R.C., Mathe A.A., Johns C.A., and Horvath T.B. Cortisol and Alzheimer's disease, I: basal studies. Am. J. Psychiatry 143 (1986) 300-305
55. de Quervain D.J., Roozendaal B., Nitsch R.M., McGaugh J.L., and Hock C. Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat. Neurosci. 3 (2000) 313-314
56. de Quidt M.E., and Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemical analysis. Neuroscience 18 (1986) 545-618
57. Delorme R., Durand C.M., Betancur C., Wagner M., Ruhrmann S., Grabe H.J., Nygren G., Gillberg C., Leboyer M., Bourgeron T., Courtet P., Jollant F., Buresi C., Aubry J.M., Baud P., Bondolfi G., Bertschy G., Perroud N., and Malafosse A. No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects. Biol. Psychiatry 60 (2006) 202-203
58. Derer P. The supraependymal fibres (SEF) of the mouse brain as visualized by the Golgi method. J. Physiol. (Paris) 77 (1981) 211-218
59. Descarries L., Watkins K.C., Garcia S., and Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J. Comp. Neurol. 207 (1982) 239-254
60. DeVito J.L., Anderson M.E., and Walsh K.E. A horseradish peroxidase study of afferent connections of the globus pallidus in Macaca mulatta. Exp. Brain Res. 38 (1980) 65-73
61. Dinopoulos A., Dori I., and Parnavelas J.G. Serotonergic innervation of the lateral geniculate nucleus of the rat during postnatal development: a light and electron microscopic immunocytochemical analysis. J. Comp. Neurol. 363 (1995) 532-544
62. Dong H., Goico B., Martin M., Csernansky C.A., Bertchume A., and Csernansky J.G. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127 (2004) 601-609
63. Dremencov E., Weizmann Y., Kinor N., Gispan-Herman I., and Yadid G. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response. Curr. Drug Targets 7 (2006) 165-175
64. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 48 (2000) 813-829
65. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11 (2001) 240-249
66. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang Y., Gautier C., and Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46 (1999) 1375-1387
67. Duan W., Lee J., Guo Z., and Mattson M.P. Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J. Mol. Neurosci. 16 (2001) 1-12
68. Duman R.S., Malberg J., and Nakagawa S. Regulation of adult neurogenesis by psychotropic drugs and stress. J. Pharmacol. Exp. Ther. 299 (2001) 401-407
69. Duman R.S., Nakagawa S., and Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25 (2001) 836-844
70. Duman R.S., Malberg J., Nakagawa S., and D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 48 (2000) 732-739
71. Duman R.S., Malberg J., Nakagawa S., and D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 48 (2000) 732-739
72. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 (2006) 1116-1127
73. Dun N.J., Dun S.L., and Forstermann U. Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience 59 (1994) 429-445
74. Eckles-Smith K., Clayton D., Bickford P., and Browning M.D. Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression. Brain Res. Mol. Brain Res. 78 (2000) 154-162
75. Egashira N., Iwasaki K., Takashima A., Watanabe T., Kawabe H., Matsuda T., Mishima K., Chidori S., Nishimura R., and Fujiwara M. Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice. Brain Res. 1059 (2005) 7-12
76. Elliott E.M., Mattson M.P., Vanderklish P., Lynch G., Chang I., and Sapolsky R.M. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61 (1993) 57-67
77. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., and Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 4 (1998) 1313-1317
78. Falck B., Hillarp N.A., Thieme G., and Torp A. Fluorescence of catecholamines and related compounds with formaldehyde. J. Histochem. Cytochem. 10 (1962) 348-354
79. Felten D.L., and Cummings J.P. The raphe nuclei of the rabbit brain stem. J. Comp. Neurol. 187 (1979) 199-243
80. Fibiger H.C., and Miller J.J. An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience 2 (1977) 975-987
81. Frankfurt M., and Azmitia E. Regeneration of serotonergic fibers in the rat hypothalamus following unilateral 5,7-dihydroxytryptamine injection. Brain Res. 298 (1984) 273-282
82. Freedman L.J., and Shi C. Monoaminergic innervation of the macaque extended amygdala. Neuroscience 104 (2001) 1067-1084
83. Fricker A.D., Rios C., Devi L.A., and Gomes I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Res. Mol. Brain Res. 138 (2005) 228-235
84. Geyer M.A., Puerto A., Dawsey W.J., Knapp S., Bullard W.P., and Mandell A.J. Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways. Brain Res. 106 (1976) 241-256
85. Glazer E.J., Steinbusch H., Verhofstad A., and Basbaum A.I. Serotonin neurons in nucleus raphe dorsalis and paragigantocellularis of the cat contain enkephalin. J. Physiol. (Paris) 77 (1981) 241-245
86. Goldman S.A., and Nottebohm F. Neuronal production, migration, and differentiation in a vocal control nucleus of the adult female canary brain. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 2390-2394
87. Gorski J.A., Balogh S.A., Wehner J.M., and Jones K.R. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience 121 (2003) 341-354
88. Graeff F.G., Guimaraes F.S., De Andrade T.G., and Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 54 (1996) 129-141
89. Graeff F.G., Silveira M.C., Nogueira R.L., Audi E.A., and Oliveira R.M. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav. Brain Res. 58 (1993) 123-131
90. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann. N.Y. Acad. Sci. 697 (1993) 53-60
91. Gray T.S., and Bingaman E.W. The amygdala: corticotropin-releasing factor, steroids, and stress. Crit. Rev. Neurobiol. 10 (1996) 155-168
92. Green K.N., Billings L.M., Roozendaal B., McGaugh J.L., and LaFerla F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26 (2006) 9047-9056
93. Green R.C., Cupples L.A., Kurz A., Auerbach S., Go R., Sadovnick D., Duara R., Kukull W.A., Chui H., Edeki T., Griffith P.A., Friedland R.P., Bachman D., and Farrer L. Depression as a risk factor for Alzheimer disease: the MIRAGE study. Arch. Neurol. 60 (2003) 753-759
94. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Ther. 65 (1995) 319-395
95. Grove E.A. Neural associations of the substantia innominata in the rat: afferent connections. J. Comp. Neurol. 277 (1988) 315-346
96. Haddjeri N., and Blier P. Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission. Biol. Psychiatry 50 (2001) 191-199
97. Halaris A.E., Jones B.E., and Moore R.Y. Axonal transport in serotonin neurons of the midbrain raphe. Brain Res. 107 (1976) 555-574
98. Halberstadt A.L., and Balaban C.D. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience 140 (2006) 1067-1077
99. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., and Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 (2002) 400-403
100. Hashimoto K., Shimizu E., and Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Brain Res. Rev. 45 (2004) 104-114
101. Haughey N.J., Nath A., Chan S.L., Borchard A.C., Rao M.S., and Mattson M.P. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J. Neurochem. 83 (2002) 1509-1524
102. Hay-Schmidt A., Vrang N., Larsen P.J., and Mikkelsen J.D. Projections from the raphe nuclei to the suprachiasmatic nucleus of the rat. J. Chem. Neuroanat. 25 (2003) 293-310
103. Heils A., Mossner R., and Lesch K.P. The human serotonin transporter gene polymorphism: basic research and clinical implications. J. Neural. Transm. 104 (1997) 1005-1014
104. Hendricksen M., Thomas A.J., Ferrier I.N., Ince P., and O'Brien J.T. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. Am. J. Psychiatry 161 (2004) 1096-1102
105. Hensler J.G., Advani T., and Monteggia L.M. Regulation of serotonin-1A receptor function in inducible brain-derived neurotrophic factor knockout mice after administration of corticosterone. Biol. Psychiatry 62 (2007) 521-529
106. Hokfelt T., Ljungdahl A., Steinbusch H., Verhofstad A., Nilsson G., Brodin E., Pernow B., and Goldstein M. Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience 3 (1978) 517-538
107. Hokfelt T., Ljungdahl A., Terenius L., Elde R., and Nilsson G. Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 3081-3085
108. Holmes A., Yang R.J., Lesch K.P., Crawley J.N., and Murphy D.L. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28 (2003) 2077-2088
109. Holmes A., Yang R.J., Murphy D.L., and Crawley J.N. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27 (2002) 914-923
110. Igarashi M., Li W.W., Sudo Y., and Fishman M.C. Ligand-induced growth cone collapse: amplification and blockade by variant GAP-43 peptides. J. Neurosci. 15 (1995) 5660-5667
111. Imai H., Steindler D.A., and Kitai S.T. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243 (1986) 363-380
112. Iritani S., Tohgi M., Arai T., and Ikeda K. Immunohistochemical study of the serotonergic neuronal system in an animal model of the mood disorder. Exp. Neurol. 201 (2006) 60-65
113. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992) 165-229
114. Jacobs B.L., Praag H., and Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 5 (2000) 262-269
115. Jankowsky J.L., and Patterson P.H. Cytokine and growth factor involvement in long-term potentiation. Mol. Cell. Neurosci. 14 (1999) 273-286
116. Jennings K.A., Loder M.K., Sheward W.J., Pei Q., Deacon R.M., Benson M.A., Olverman H.J., Hastie N.D., Harmar A.J., Shen S., and Sharp T. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J. Neurosci. 26 (2006) 8955-8964
117. Jiang X., Xu K., Hoberman J., Tian F., Marko A.J., Waheed J.F., Harris C.R., Marini A.M., Enoch M.A., and Lipsky R.H. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30 (2005) 1353-1361
118. Johnson M.D., and Ma P.M. Localization of NADPH diaphorase activity in monoaminergic neurons of the rat brain. J. Comp. Neurol. 332 (1993) 391-406
119. Kaneko T., Akiyama H., Nagatsu I., and Mizuno N. Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain. Brain Res. 507 (1990) 151-154
120. Karege F., Vaudan G., Schwald M., Perroud N., and La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 136 (2005) 29-37
121. Karlstedt K., Nissinen M., Michelsen K.A., and Panula P. Multiple sites of l-histidine decarboxylase expression in mouse suggest novel developmental functions for histamine. Dev. Dyn. 221 (2001) 81-91
122. Kellar K.J., Brown P.A., Madrid J., Bernstein M., Vernikos-Danellis J., and Mehler W.R. Origins of serotonin innervation of forebrain structures. Exp. Neurol. 56 (1977) 52-62
123. Kempermann G., Kuhn H.G., and Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 386 (1997) 493-495
124. Kim M.W., Bang M.S., Han T.R., Ko Y.J., Yoon B.W., Kim J.H., Kang L.M., Lee K.M., and Kim M.H. Exercise increased BDNF and trkB in the contralateral hemisphere of the ischemic rat brain. Brain Res. 1052 (2005) 16-21
125. Kirifides M.L., Simpson K.L., Lin R.C., and Waterhouse B.D. Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat. J. Comp. Neurol. 435 (2001) 325-340
126. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., and Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 415-419
127. Kohler C., Chan-Palay V., and Steinbusch H. The distribution and origin of serotonin-containing fibers in the septal area: a combined immunohistochemical and fluorescent retrograde tracing study in the rat. J. Comp. Neurol. 209 (1982) 91-111
128. Kohler C., and Steinbusch H. Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 7 (1982) 951-975
129. Kosofsky B.E., and Molliver M.E. The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1 (1987) 153-168
130. Kunugi H., Ueki A., Otsuka M., Isse K., Hirasawa H., Kato N., Nabika T., Kobayashi S., and Nanko S. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol. Psychiatry 6 (2001) 83-86
131. Lee J., Duan W., Long J.M., Ingram D.K., and Mattson M.P. Dietary restriction increases the number of newly generated neural cells, and induces BDNF expression, in the dentate gyrus of rats. J. Mol. Neurosci. 15 (2000) 99-108
132. Lee J., Duan W., and Mattson M.P. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 82 (2002) 1367-1375
133. Leger L., and Wiklund L. Distribution and numbers of indoleamine cell bodies in the cat brainstem determined with Falck-Hillarp fluorescence histochemistry. Brain Res. Bull. 9 (1982) 245-251
134. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., and Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23 (2003) 8788-8799
135. Leonard B.E. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur. Psychiatry 20 Suppl. 3 (2005) S302-S306
136. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
137. Lieske V., Bennett-Clarke C.A., and Rhoades R.W. Effects of serotonin on neurite outgrowth from thalamic neurons in vitro. Neuroscience 90 (1999) 967-974
138. Lima L., Matus P., and Urbina M. Serotonin inhibits outgrowth of goldfish retina and impairs the trophic effect of taurine. J. Neurosci. Res. 38 (1994) 444-450
139. Lindvall O., and Bjorklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta. Physiol. Scand. Suppl. 412 (1974) 1-48
140. Lopez-Figueroa A.L., Norton C.S., Lopez-Figueroa M.O., Armellini-Dodel D., Burke S., Akil H., Lopez J.F., and Watson S.J. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol. Psychiatry 55 (2004) 225-233
141. Lorez H.P., and Richards J.G. Supra-ependymal serotoninergic nerves in mammalian brain: morphological, pharmacological and functional studies. Brain Res. Bull. 9 (1982) 727-741
142. Lossi L., Bottarelli L., Candusso M.E., Leiter A.B., Rindi G., and Merighi A. Transient expression of secretin in serotoninergic neurons of mouse brain during development. Eur. J. Neurosci. 20 (2004) 3259-3269
143. Lotto B., Upton L., Price D.J., and Gaspar P. Serotonin receptor activation enhances neurite outgrowth of thalamic neurones in rodents. Neurosci. Lett. 269 (1999) 87-90
144. Lovick T.A., and Hunt S.P. Substance P-immunoreactive and serotonin-containing neurones in the ventral brainstem of the cat. Neurosci. Lett. 36 (1983) 223-228
145. Lowry C.A. Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 14 (2002) 911-923
146. Lowther S., De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., and Horton R.W. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J. Affect Disord. 42 (1997) 199-207
147. Madsen T.M., Treschow A., Bengzon J., Bolwig T.G., Lindvall O., and Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol. Psychiatry 47 (2000) 1043-1049
148. Mahncke H.W., Bronstone A., and Merzenich M.M. Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog. Brain Res. 157 (2006) 81-109
149. Maier S.F., and Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 29 (2005) 829-841
150. Malberg J.E. Implications of adult hippocampal neurogenesis in antidepressant action. J. Psychiatry Neurosci. 29 (2004) 196-205
151. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20 (2000) 9104-9110
152. Mamounas L.A., Blue M.E., Siuciak J.A., and Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15 (1995) 7929-7939
153. Mamounas L.A., and Molliver M.E. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp. Neurol. 102 (1988) 23-36
154. Mamounas L.A., Mullen C.A., O'Hearn E., and Molliver M.E. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314 (1991) 558-586
155. Manji H.K., Gottesman I.I., and Gould T.D. Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci. STKE 2003 (2003) e49
156. Masugi F., Ogihara T., Sakaguchi K., Otsuka A., Tsuchiya Y., Morimoto S., Kumahara Y., Saeki S., and Nishide M. High plasma levels of cortisol in patients with senile dementia of the Alzheimer's type. Methods Find. Exp. Clin. Pharmacol. 11 (1989) 707-710
157. Matsushita S., Arai H., Matsui T., Yuzuriha T., Urakami K., Masaki T., and Higuchi S. Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J. Neural. Transm. 112 (2005) 703-711
158. Mattson M.P., Maudsley S., and Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 27 (2004) 589-594
159. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 65 (2003) 193-207
160. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A., and Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760 (1997) 68-73
161. McCay C.M., Crowell M.F., and Maynard L.A. The effect of retarded growth
162. McQuade R., and Sharp T. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem. 69 (1997) 791-796
163. Melander T., Hokfelt T., Rokaeus A., Cuello A.C., Oertel W.H., Verhofstad A., and Goldstein M. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci. 6 (1986) 3640-3654
164. Meyer-Bernstein E.L., and Morin L.P. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J. Neurosci. 16 (1996) 2097-2111
165. Michelsen K.A., Schmitz C., and Steinbusch H.W. The dorsal raphe nucleus: from silver stainings to a role in depression. Brain Res. Rev. 55 (2007) 329-342
166. Miller J.J., Richardson T.L., Fibiger H.C., and McLennan H. Anatomical and electrophysiological identification of a projection from the mesencephalic raphe to the caudate-putamen in the rat. Brain Res. 97 (1975) 133-136
167. Mintun M.A., Sheline Y.I., Moerlein S.M., Vlassenko A.G., Huang Y., and Snyder A.Z. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biol. Psychiatry 55 (2004) 217-224
168. Momma S., Johansson C.B., and Frisen J. Get to know your stem cells. Curr. Opin. Neurobiol. 10 (2000) 45-49
169. Monteggia L.M., Luikart B., Barrot M., Theobold D., Malkovska I., Nef S., Parada L.F., and Nestler E.J. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry 61 (2007) 187-197
170. Morin L.P., and Meyer-Bernstein E.L. The ascending serotonergic system in the hamster: comparison with projections of the dorsal and median raphe nuclei. Neuroscience 91 (1999) 81-105
171. Moss M.S., Glazer E.J., and Basbaum A.I. Enkephalin neurons in the raphe dorsalis and periaqueductal grey of the cat: a comparison with substance. P. Anat. Rec. 196 (1980) 131A
172. Moss M.S., Glazer E.J., and Basbaum A.I. Enkephalin-immunoreactive perikarya in the cat raphe dorsalis. Neurosci. Lett. 21 (1981) 33-37
173. Mugnaini E., and Oertel W.H. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A., and Hökfelt T. (Eds). Handbook of Chemical Neuroanatomy, Vol. 4. GABA and Neuropeptides in the CNS. Part I (1985), Elsevier Science Publishers, B.V., Amsterdam 436-608
174. Muller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J., Holsboer F., and Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur. J. Neurosci. 14 (2001) 1603-1612
175. Mulligan K.A., and Tork I. Serotoninergic innervation of the cat cerebral cortex. J. Comp. Neurol. 270 (1988) 86-110
176. Murer M.G., Boissiere F., Yan Q., Hunot S., Villares J., Faucheux B., Agid Y., Hirsch E., and Raisman-Vozari R. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 88 (1999) 1015-1032
177. Nagai T., McGeer P.L., and McGeer E.G. Distribution of GABA-T-intensive neurons in the rat forebrain and midbrain. J. Comp. Neurol. 218 (1983) 220-238
178. Nagatsu I., Inagaki S., Kondo Y., Karasawa N., and Nagatsu T. Immunofluorescent studies on the localization of tyrosine hydroxylase and dopamine-â-hydroxylase in the mes-, di-, and telencephalon of the rat using unperfused fresh frozen sections. Acta Histochem. Cytochem. 12 (1979) 20-37
179. Nakahama H., Shima K., Yamamoto M., and Aya K. Regularity of the spontaneous discharge of neurons in the nucleus raphe dorsalis of the cat. Neurosci. Lett. 23 (1981) 161-165
180. Nakamura H., Saheki T., Ichiki H., Nakata K., and Nakagawa S. Immunocytochemical localization of argininosuccinate synthetase in the rat brain. J. Comp. Neurol. 312 (1991) 652-679
181. Narisawa-Saito M., Wakabayashi K., Tsuji S., Takahashi H., and Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 7 (1996) 2925-2928
182. Neeper S.A., Gómez-Pinilla F., Choi J., and Cotman C.W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 726 (1996) 49-56
183. Nelson R.L., Guo Z., Halagappa V.M., Pearson M., Gray A.J., Matsuoka Y., Brown M., Martin B., Iyun T., Maudsley S., Clark R.F., and Mattson M.P. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp. Neurol. 205 (2007) 166-176
184. Newcomer J.W., Selke G., Melson A.K., Hershey T., Craft S., Richards K., and Alderson A.L. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch. Gen. Psychiatry 56 (1999) 527-533
185. Newton S.S., Thome J., Wallace T.L., Shirayama Y., Schlesinger L., Sakai N., Chen J., Neve R., Nestler E.J., and Duman R.S. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22 (2002) 10883-10890
186. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
187. Nissinen M.J., Karlstedt K., Castren E., and Panula P. Expression of histidine decarboxylase and cellular histamine-like immunoreactivity in rat embryogenesis. J. Histochem. Cytochem. 43 (1995) 1241-1252
188. Nissinen M.J., and Panula P. Developmental patterns of histamine-like immunoreactivity in the mouse. J. Histochem .Cytochem. 43 (1995) 211-227
189. Nobin A., Baumgarten H.G., Björklund A., Lachenmayer L., and Stenevi U. Axonal degeneration and regeneration of bulbo-spinal indolamine neurons after 5,6-dihydroxytryptamine treatment. Brain Res. 56 (1973) 1-24
190. Ochi J., and Shimizu K. Occurence of dopamine-containing neurons in the midbrain raphe nuclei of the rat. Neurosci. Lett. 8 (1978) 317-320
191. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., and Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8 (1988) 2788-2803
192. O'Hearn E., and Molliver M.E. Organization of raphe-cortical projections in rat: a quantitative retrograde study. Brain. Res. Bull. 13 (1984) 709-726
193. Olin J.T., Katz I.R., Meyers B.S., Schneider L.S., and Lebowitz B.D. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am. J. Geriatr. Psychiatry 10 (2002) 129-141
194. Otake K. Cholecystokinin and substance P immunoreactive projections to the paraventricular thalamic nucleus in the rat. Neurosci. Res. 51 (2005) 383-394
195. Ownby R.L., Crocco E., Acevedo A., John V., and Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 63 (2006) 530-538
196. Palmer A.M., Francis P.T., Benton J.S., Sims N.R., Mann D.M., Neary D., Snowden J.S., and Bowen D.M. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem. 48 (1987) 8-15
197. Parsons A.A. 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol. Sci. 12 (1991) 310-315
198. Pasqualotto B.A., Hope B.T., and Vincent S.R. Citrulline in the rat brain: immunohistochemistry and coexistence with NADPH-diaphorase. Neurosci. Lett. 128 (1991) 155-160
199. Pau K.Y., Yu J.H., Lee C.J., and Spies H.G. Topographic localization of neuropeptide Y mRNA in the monkey brainstem. Regul. Pept. 75-76 (1998) 145-153
200. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego, CA
201. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego, CA
202. Paykel E.S., Brugha T., and Fryers T. Size and burden of depressive disorders in Europe. Eur. Neuropsychopharmacol. 15 (2005) 411-423
203. Petrov T., Krukoff T.L., and Jhamandas J.H. The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: a combined double retrograde and immunocytochemical study. J. Comp. Neurol. 318 (1992) 18-26
204. Petrov T., Krukoff T.L., and Jhamandas J.H. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res. 277 (1994) 289-295
205. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., and Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7 (1991) 695-702
206. Pierce E.T., Foote W.E., and Hobson J.A. The efferent connection of the nucleus raphe dorsalis. Brain Res. 107 (1976) 137-144
207. Pomara N., Greenberg W.M., Branford M.D., and Doraiswamy P.M. Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. Psychopharmacol. Bull. 37 (2003) 120-134
208. Prolla T.A., and Mattson M.P. Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci. 24 (2001) S21-S31
209. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., and Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14476-14481
210. Rapp M.A., Schnaider-Beeri M., Grossman H.T., Sano M., Perl D.P., Purohit D.P., Gorman J.M., and Haroutunian V. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry 63 (2006) 161-167
211. Ren-Patterson R.F., Cochran L.W., Holmes A., Sherrill S., Huang S.J., Tolliver T., Lesch K.P., Lu B., and Murphy D.L. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J. Neurosci. Res. 79 (2005) 756-771
212. Richards J.G. Cytochemistry and autoradiography in the search for transmitter-specific neuronal pathways. In: Coupland R.E., and Forssmann W.G. (Eds). Peripheral Neuroendocrine Interaction (1978), Springer, Heidelberg 1-14
213. Richards J.G., Lorez H.P., and Tranzer J.P. Indolealkylamine nerve terminals in cerebral ventricles: identification by electron microscopy and fluorescence histochemistry. Brain Res. 57 (1973) 277-288
214. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Moreno V., Martinez-Murillo R., Polak J.M., and Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345 (1994) 175-221
215. Rosel P., Arranz B., San L., Vallejo J., Crespo J.M., Urretavizcaya M., and Navarro M.A. Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Res. 99 (2000) 173-181
216. Rosel P., Arranz B., Urretavizcaya M., Oros M., San L., and Navarro M.A. Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology 49 (2004) 189-195
217. Rosel P., Arranz B., Vallejo J., Oros M., Crespo J.M., Menchon J.M., and Navarro M.A. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains. Psychiatry Res. 82 (1998) 161-170
218. Rupniak N.M., and Kramer M.S. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol. Sci. 20 (1999) 485-490
219. Russo-Neustadt A., Beard R.C., and Cotman C.W. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21 (1999) 679-682
220. Russo-Neustadt A.A., Beard R.C., Huang Y.M., and Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101 (2000) 305-312
221. Sadikot A.F., and Parent A. The monoaminergic innervation of the amygdala in the squirrel monkey: an immunohistochemical study. Neuroscience 36 (1990) 431-447
222. Saito S., Kobayashi S., Ohashi Y., Igarashi M., Komiya Y., and Ando S. Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents. J. Neurosci. Res. 39 (1994) 57-62
223. Sakai K., and Crochet S. Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake-sleep states. Neuroscience 104 (2001) 1141-1155
224. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
225. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmal C., Hofels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nothen M.M., and Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58 (2005) 307-314
226. Segal M. Afferents to the entorhinal cortex of the rat studied by the method of retrograde transport of horseradish peroxidase. Exp. Neurol. 57 (1977) 750-765
227. Segal M., and Landis S. Afferents to the hippocampus of the rat studied with the method of retrograde transport of horseradish peroxidase. Brain Res. 78 (1974) 1-15
228. Severin E.S., and Kondratyev A.D. Regulation of differentiation of PC12 cells by nerve growth factor. Adv. Enzyme Regul. 27 (1988) 357-370
229. Sheline Y.I., Gado M.H., and Kraemer H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 160 (2003) 1516-1518
230. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3908-3913
231. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22 (2002) 3251-3261
232. Sim L.J., and Joseph S.A. Dorsal raphe nucleus efferents: termination in peptidergic fields. Peptides 14 (1993) 75-83
233. Sims K.B., Hoffman D.L., Said S.I., and Zimmerman E.A. Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain Res. 186 (1980) 165-183
234. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56 (1997) 131-137
235. Skofitsch G., and Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 6 (1985) 509-546
236. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15 (1995) 1768-1777
237. Soares J.C., and Mann J.J. The functional neuroanatomy of mood disorders. J. Psychiatr. Res. 31 (1997) 393-432
238. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
239. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6 (1981) 557-618
240. Steinbusch H.W. Serotonin-immunoreactive neurons and their projections in the CNS. In: Bjorklund A., and Hokfelt T. (Eds). Handbook of Chemical Neuroanatomy Vol. 3 (1984), Elsevier, New York 68-125
241. Steinbusch H.W., Nieuwenhuys R., Verhofstad A.A., and van der K.D. The nucleus raphe dorsalis of the rat and its projection upon the caudatoputamen. A combined cytoarchitectonic, immunohistochemical and retrograde transport study. J. Physiol. (Paris) 77 (1981) 157-174
242. Steinbusch H.W.M., and Nieuwenhuys R. Localization of serotonin-like immunoreactivity in the central nervous system and pituitary of the rat, with special references to the innervation of the hypothalamus. In: Haber B., and Gabay S. (Eds). Serotonin: Current Aspects of Neurochemistry and Function (1982), Plenum Press, New York 7-35
243. Stockmeier C.A., Mahajan G.J., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., Uylings H.B., Friedman L., and Rajkowska G. Cellular changes in the postmortem hippocampus in major depression. Biol. Psychiatry 56 (2004) 640-650
244. Stratford T.R., and Wirtshafter D. Ascending dopaminergic projections from the dorsal raphe nucleus in the rat. Brain Res. 511 (1990) 173-176
245. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., Vaugeois J.M., Nomikos G.G., and Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311 (2006) 77-80
246. Svenningsson P., and Greengard P. p11 (S100A10): an inducible adaptor protein that modulates neuronal functions. Curr. Opin. Pharmacol. 7 (2007) 27-32
247. Swanwick G.R., Kirby M., Bruce I., Buggy F., Coen R.F., Coakley D., and Lawlor B.A. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings. Am. J. Psychiatry 155 (1998) 286-289
248. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., and Malhotra A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10 (2005) 631-636
249. Taber E., Brodal A., and Walberg F. The raphe nuclei of the brain stem in the cat. I. Normal topography and cytoarchitecture and general discussion. J. Comp. Neurol. 114 (1960) 161-187
250. Tejani-Butt S.M., Yang J., and Pawlyk A.C. Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus. Neuroreport 6 (1995) 1207-1210
251. Tork I. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600 (1990) 9-34
252. Tsai S.J. Brain-derived neurotrophic factor: a bridge between major depression and Alzheimer's disease?. Med. Hypotheses 61 (2003) 110-113
253. Uhl G.R., Goodman R.R., Kuhar M.J., Childers S.R., and Snyder S.H. Immunohistochemical mapping of enkephalin containing cell bodies, fibers and nerve terminals in the brain stem of the rat. Brain Res. 166 (1979) 75-94
254. Valentino R.J., Bey V., Pernar L., and Commons K.G. Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J. Neurosci. 23 (2003) 7155-7159
255. Valentino R.J., and Commons K.G. Peptides that fine-tune the serotonin system. Neuropeptides 39 (2005) 1-8
256. Van Bockstaele E.J., Biswas A., and Pickel V.M. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res. 624 (1993) 188-198
257. Van Bockstaele E.J., and Pickel V.M. Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents. J. Comp. Neurol. 334 (1993) 603-617
258. van de Kar L.D., and Lorens S.A. Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei. Brain Res. 162 (1979) 45-54
259. van der Kooy D., and Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res. 186 (1980) 1-7
260. van der Kooy D., and Hattori T. Bilaterally situated dorsal raphe cell bodies have only unilateral forebrain projections in rat. Brain Res. 192 (1980) 550-554
261. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313 (1991) 643-668
262. Wallace T.L., Stellitano K.E., Neve R.L., and Duman R.S. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol. Psychiatry 56 (2004) 151-160
263. Wang Q.P., Guan J.L., and Nakai Y. Distribution and synaptic relations of NOS neurons in the dorsal raphe nucleus: a comparison to 5-HT neurons. Brain Res. Bull. 37 (1995) 177-187
264. Wang Q.P., Ochiai H., and Nakai Y. GABAergic innervation of serotonergic neurons in the dorsal raphe nucleus of the rat studied by electron microscopy double immunostaining. Brain Res. Bull. 29 (1992) 943-948
265. Waselus M., Galvez J.P., Valentino R.J., and Van Bockstaele E.J. Differential projections of dorsal raphe nucleus neurons to the lateral septum and striatum. J. Chem. Neuroanat. 31 (2006) 233-242
266. Wiklund L., Leger L., and Persson M. Monoamine cell distribution in the cat brain stem. A fluorescence histochemical study with quantification of indolaminergic and locus coeruleus cell groups. J. Comp. Neurol. 203 (1981) 613-647
267. Wolf S.A., Kronenberg G., Lehmann K., Blankenship A., Overall R., Staufenbiel M., and Kempermann G. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol. Psychiatry 60 (2006) 1314-1323
268. Wotherspoon G., Albert M., Rattray M., and Priestley J.V. Serotonin and NADPH-diaphorase in the dorsal raphe nucleus of the adult rat. Neurosci. Lett. 173 (1994) 31-36
269. Wu Z.L., Ciallella J.R., Flood D.G., O'Kane T.M., Bozyczko-Coyne D., and Savage M.J. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol. Aging 27 (2006) 377-386
270. Wyss J.M., Swanson L.W., and Cowan W.M. A study of subcortical afferents to the hippocampal formation in the rat. Neuroscience 4 (1979) 463-476
271. Xu H., Chen Z., He J., Haimanot S., Li X., Dyck L., and Li X.M. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16 (2006) 551-559
272. Xu H., Qing H., Lu W., Keegan D., Richardson J.S., Chlan-Fourney J., and Li X.M. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci. Lett. 321 (2002) 65-68
273. Yager J.Y., Wright S., Armstrong E.A., Jahraus C.M., and Saucier D.M. The influence of aging on recovery following ischemic brain damage. Behav. Brain Res. 173 (2006) 171-180
274. Yamamoto T., and Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann. Neurol. 17 (1985) 573-577
275. Yoshida K., McCormack S., España R.A., Crocker A., and Scammell T.E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494 (2006) 845-861
276. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305 (2004) 217
277. Zhang X., Gainetdinov R.R., Beaulieu J.M., Sotnikova T.D., Burch L.H., Williams R.B., Schwartz D.A., Krishnan K.R., and Caron M.G. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45 (2005) 11-16
278. Zhang X., Gainetdinov R.R., Beaulieu J.M., Sotnikova T.D., Burch L.H., Williams R.B., Schwartz D.A., Krishnan K.R., and Caron M.G. Response to correspondence: loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 48 (2005) 705-706
279. Zobel A., Joe A., Freymann N., Clusmann H., Schramm J., Reinhardt M., Biersack H.J., Maier W., and Broich K. Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Res. 139 (2005) 165-179
280. Zweig R.M., Ross C.A., Hedreen J.C., Steele C., Cardillo J.E., Whitehouse P.J., Folstein M.F., and Price D.L. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann. Neurol. 24 (1988) 233-242